Eyes as the windows into cardiovascular disease in the era of big data

Yarn Kit Chan1, Ching-Yu Cheng1,2,3,4, Charumathi Sabanayagam1,2

  • 1Ophthalmology and Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore.

PubMed

Insights

Deep learning algorithms (DLAs) analyze ocular images to predict cardiovascular disease (CVD) risk factors and outcomes. This review explores DLAs

Area of Science:

  • Cardiology
  • Ophthalmology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Cardiovascular disease (CVD) is a leading global cause of death and disability.
  • Ocular images contain rich information correlated with CVD progression.
  • Early diagnosis and risk stratification are crucial for managing CVD.

Purpose of the Study:

  • To review recent deep learning algorithms (DLAs) applied to ocular images for CVD outcomes.
  • To identify challenges and future directions for clinical deployment of these DLAs.
  • To explore the burgeoning intersection of cardio-oculomics.

Main Methods:

  • Systematic review of 17 recent DLAs utilizing ocular images for CVD prediction.
  • Analysis of DLAs' ability to predict cardiovascular risk factors and disease outcomes.
  • Assessment of current challenges and requirements for clinical implementation.

Main Results:

  • DLAs accurately predict various cardiovascular risk factors (e.g., hypertension) and outcomes (e.g., stroke, myocardial infarction) from retinal fundus photographs.
  • DLAs demonstrate significant accuracy in predicting associated conditions like chronic kidney disease and hematological disorders.
  • The field shows promise, with potential to predict age, sex, and lifestyle factors from ocular data.

Conclusions:

  • Deep learning applied to ocular imaging shows significant promise for early CVD detection and risk assessment.
  • Further research is needed to improve generalizability, external validation, and benchmarking for widespread clinical adoption.
  • The cardio-oculomics field is rapidly growing, offering potential for personalized precision medicine in cardiovascular healthcare.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
369
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
44
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
595
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
383